JNJ-63733657

· Janssen Pharmaceutical K.K.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for JNJ-63733657, covering 2025-04-27 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease [Phase 2]